Exact Mass: 420.3391974
Exact Mass Matches: 420.3391974
Found 168 metabolites which its exact mass value is equals to given mass value 420.3391974,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3b,5a,6b-Cholestanetriol
3b,5a,6b-Cholestanetriol is a product of cholesterol oxidation found in human plasma. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane
3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is found in the primary bile acid biosynthesis pathway. 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is produced from 3 alpha,7 alpha-Dihydroxy-5beta-cholestane through the action of CYP27A (E1.14.13.15). 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is then converted to 3 alpha,7 alpha-Dihydroxy-5beta-cholestan-26-al by CYP27A (E1.14.13.15). 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is found in the primary bile acid biosynthesis pathway.
5beta-Cholestane-3alpha,7alpha,12alpha-triol
5beta-Cholestane-3alpha,7alpha,12alpha-triol is an intermediate in bile acid biosynthesis. 5beta-Cholestane-3alpha,7alpha,12alpha-triol is the second to last step in the synthesis of 5beta-cyprinolsulfate. It is converted from 7alpha,12alpha-dihydroxy-5beta-cholestan-3-one via enzymatic reaction, and then it is converted into 3alpha,7alpha,12alpha,26-tetrahydroxy-5beta-cholestane via the enzyme cytochrome P450 (EC 1.14.13.15). This compound inhibits la-hydroxylation (PMID: 7937829). It is the byproduct of cholestanetetraol 26-dehydrogenase (EC 1.1.1.161) and the reaction that catalyzes it is classified as a small molecule reaction (BioCyc). 5-b-Cholestane-3a ,7a ,12a-triol is an intermediate in Bile acid biosynthesis. 5-b-Cholestane-3a ,7a ,12a-triol is the second to last step of synthesis of 5beta-Cyprinolsulfate. It is converted from 7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one via enzymatic reaction then it is coneverted to 3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane via the enzyme cytochrome P450(EC.1.14.13.15). This compound inhibits la-Hydroxylation, (PMID: 7937829). It is the byproduct of Cholestanetetraol 26-dehydrogenase (EC 1.1.1.161), and the reaction that cataylzes it is classified as a small molecule reaction. (BioCyc) [HMDB]
6-ECDCA
A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy > A05AA - Bile acids and derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D09360
5beta-Cholestane-3alpha,7alpha,27-triol
This compound belongs to the family of Cholesterols and Derivatives. These are compounds containing an hydroxylated chloestane moeity.
5beta-Cholestane-3alpha,7alpha,24-triol
5beta-Cholestane-3alpha,7alpha,24-triol is also known as 5β-cholestan-3α,7α,24-triol. 5beta-Cholestane-3alpha,7alpha,24-triol is considered to be practically insoluble (in water) and basic. 5beta-Cholestane-3alpha,7alpha,24-triol is a bile acid lipid molecule
(3alpha,5alpha,22R,23R)-Cholestane-3,22,23-triol
(3alpha,5alpha,22R,23R)-Cholestane-3,22,23-triol is found in garden tomato. (3alpha,5alpha,22R,23R)-Cholestane-3,22,23-triol is a constituent of tomato (Lycopersicon esculentum).
6-Ethylchenodeoxycholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Cholestane-3,5,6-triol
Cholestanetriol
6-Deoxo-28-nortyphasterol
(6E,9E,12E,15E,18E,21E)-2-tetracosa-6,9,12,15,18,21-hexaenylpenta-2,4-dien-4-olide
3alpha-amino-23,29-imino-B(9a)-homo-19-nor-5alpha-stigmasta-1(10),7,9(11),23(N)-tetraene
(1beta,3beta,5alpha,6beta,22E)-24-norcholest-22-ene-1,3,5,6-tetrol|(22E)-24-norcholest-22-ene-1beta,3beta,5alpha,6beta-tetraol|(22E)-24-norcholest-22-ene-1beta,3beta,5alpha,6beta-tetrol|anthogorgsteroid D
calotroprocerone A|ursa-5,12,20(30)-trien-18aH-3-one
(2beta, 3beta, 5alpha, 6abeta)-Cholestane-2, 3, 6-triol
(E)-26,27-dinor-24xi-methyl-5alpha-cholest-22-ene-3beta,6alpha,15beta,25-tetrol|certonardosterol H
13alpha,17-Dihydroxy-19-(3-methylvaleryloxy)villanovan|19-O-(3-Methylpentanoyl)-(ent-13beta)-13, 17, 19-Villanovanetriol
(3R,5S,7R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3S,5R,7R,9S,10S,13R,14S,17R)-17-((2R)-7-hydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol
4,4-difluorovitamin D3 / 4,4-difluorocholecalciferol
(5Z)-4,4-difluorovitamin D3 / (5Z)-4,4-difluorocholecalciferol
(5Z,7E)-(1S,3R)-22-(3-methylphenyl)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
(7E)-(1R,2S,3R)-19-nor-9,10-seco-5,7-cholestadiene-1,2,3,25-tetrol
(7E)-(1R,2R,3R)-19-nor-9,10-seco-5,7-cholestadiene-1,2,3,25-tetrol
3Alpha,7Alpha,12Alpha-trihydroxy-27-nor-5Beta-cholestan-24-one
1alpha-hydroxy-22-(3-methylphenyl)-23,24,25,26,27-pentanorvitamin D3
1alpha,2beta,25-trihydroxy-19-norvitamin D3
4-pentylphenyl 4-(trans-4-pentylcyclohexyl)-benzoate
6-(isononanoylamino)hexanoic acid, compound with 2,2,2-nitrilotriethanol (1:1)
ammonium sulfobetaine-1, tech., 70
C21H44N2O4S (420.30216240000004)
ethyl 2-(m-tert-butyl-p-hydroxyphenoxy)tetradecanoate
N-methyl-N-(1-oxododecyl)glycine, compound with 2,2,2-nitrilotri(ethanol) (1:1)
4-Heptylphenyl 4-(trans-4-propylcyclohexyl)benzoate
1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxo-hexadecyl)amino]-, chloride
2-fluoro-4,4-bis((1s,4r)-4-propylcyclohexyl)-1,1-biphenyl
2-DODECYL-N-(1,2,2,6,6-PENTAMETHYL-4-PIPERIDINYL)SUCCINIMIDE
C26H48N2O2 (420.37155879999995)
(3alpha,5beta,6alpha,7beta)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,6beta,7alpha)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
17-(1,5-Dimethylhexyl)-10,13-dimethylhexadecahydrocyclopenta[a]phenanthrene-3,5,6-triol
Cholestane-3,5,6-triol
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
Obeticholic acid
A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy > A05AA - Bile acids and derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
3b,5a,6b-Cholestanetriol
3b,5a,6b-Cholestanetriol is a product of cholesterol oxidation found in human plasma. [HMDB]
1alpha-hydroxy-22-(3-methylphenyl)-23,24,25,26,27-pentanorvitamin D3/1alpha-hydroxy-22-(3-methylphenyl)-23,24,25,26,27-pentanorcholecalciferol
[3-carboxy-2-[(4Z,8Z,12Z,15Z)-octadeca-4,8,12,15-tetraenoyl]oxypropyl]-trimethylazanium
C25H42NO4+ (420.31136720000006)
[3-carboxy-2-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxypropyl]-trimethylazanium
C25H42NO4+ (420.31136720000006)
(24S)-5beta-cholestane-3alpha,7alpha,24-triol
5beta-Cholestane-3alpha,7alpha,24-triol with S-configuration at C-24.
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] heptanoate
[1-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] propanoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] pentanoate
2-[Carboxy-(2-hydroxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
C21H42NO7+ (420.29611220000004)
3β,5α,6β-Trihydroxycholestane
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites